Across TCGA pan-cancer cohorts, FAM210CP RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of FAM210CP’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where FAM210CP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FAM210CP is over-expressed in tumor, although a few such as THCA and READ show the opposite, repressed pattern.

COAD, THCA, and READ are the cancer types where FAM210CP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAM210CP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	+0.323	.017	4	view →
THCA	Female	All	−0.154	.007	2	view →
READ	All	III,IV	−0.145	.028	2	view →
KICH	Female	III,IV	+0.196	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: FAM210CP RNA expression & survival · all FAM210CP data types